117 related articles for article (PubMed ID: 35537008)
21. Second malignancy in 597 patients with ewing sarcoma of bone treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999.
Bacci G; Longhi A; Barbieri E; Ferrari S; Mercuri M; Briccoli A; Versari M; Pignotti E; Picci P
J Pediatr Hematol Oncol; 2005 Oct; 27(10):517-20. PubMed ID: 16217253
[TBL] [Abstract][Full Text] [Related]
22. A phase II study to determine the efficacy and safety of oral treosulfan in patients with advanced pre-treated Ewing sarcoma ISRCTN11631773.
Michelagnoli M; Whelan J; Forsyth S;
Pediatr Blood Cancer; 2015 Jan; 62(1):158-9. PubMed ID: 25284019
[TBL] [Abstract][Full Text] [Related]
23. Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.
Czyzewski EA; Goldman S; Mundt AJ; Nachman J; Rubin C; Hallahan DE
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):569-77. PubMed ID: 10348286
[TBL] [Abstract][Full Text] [Related]
24. Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.
Ladenstein R; Pötschger U; Le Deley MC; Whelan J; Paulussen M; Oberlin O; van den Berg H; Dirksen U; Hjorth L; Michon J; Lewis I; Craft A; Jürgens H
J Clin Oncol; 2010 Jul; 28(20):3284-91. PubMed ID: 20547982
[TBL] [Abstract][Full Text] [Related]
25. A modified protocol with vincristine, topotecan, and cyclophosphamide for recurrent/progressive ewing sarcoma family tumors.
Kebudi R; Cakir FB; Gorgun O; Agaoglu FY; Darendeliler E
Pediatr Hematol Oncol; 2013 Apr; 30(3):170-7. PubMed ID: 23484903
[TBL] [Abstract][Full Text] [Related]
26. Improved Outcome in Local Ewing Sarcoma With an Intensified Pilot Treatment Protocol SCMCIE 94.
Ash S; Yaniv I; Toledano H; Stein J; Kollender Y; Fenig E; Konen O; Bar-Sever Z; Issakov J; Avigad S; Cohen IJ
J Pediatr Hematol Oncol; 2019 Mar; 41(2):105-111. PubMed ID: 30570510
[TBL] [Abstract][Full Text] [Related]
27. Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma.
Bosma SE; Rueten-Budde AJ; Lancia C; Ranft A; Dirksen U; Krol AD; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Fiocco M
Pediatr Blood Cancer; 2019 Nov; 66(11):e27943. PubMed ID: 31389188
[TBL] [Abstract][Full Text] [Related]
28. High-dose chemotherapy followed by autologous stem cell transplantation for adult patients With first relapse of Ewing's sarcoma: A single institution experience.
Paksoy N; Ferhatoglu F; Dogan İ; Khanmammadov N; Iribas Celik A; Gulbas Z; Başaran M
Medicine (Baltimore); 2022 Dec; 101(49):e32213. PubMed ID: 36626465
[TBL] [Abstract][Full Text] [Related]
29. Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation.
Oesterheld JE; Reed DR; Setty BA; Isakoff MS; Thompson P; Yin H; Hayashi M; Loeb DM; Smith T; Makanji R; Fridley BL; Wagner LM
Pediatr Blood Cancer; 2020 Jul; 67(7):e28370. PubMed ID: 32386107
[TBL] [Abstract][Full Text] [Related]
30. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
[TBL] [Abstract][Full Text] [Related]
31. Intensive combined modality therapy including low-dose TBI in high-risk Ewing's Sarcoma Patients.
Kinsella TJ; Glaubiger D; Diesseroth A; Makuch R; Waller B; Pizzo P; Glatstein E
Int J Radiat Oncol Biol Phys; 1983 Dec; 9(12):1955-60. PubMed ID: 9463099
[TBL] [Abstract][Full Text] [Related]
32. Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group.
Collier AB; Krailo MD; Dang HM; DuBois SG; Hawkins DS; Bernstein ML; Bomgaars LR; Reed DR; Gorlick RG; Janeway KA
Pediatr Blood Cancer; 2021 Dec; 68(12):e29333. PubMed ID: 34496122
[TBL] [Abstract][Full Text] [Related]
33. Retrospective Analysis of Outcomes of Patients with Relapsed, Refractory and Metastatic Sarcomas who have received Metronomic Chemotherapy.
Devadas SK; Banavali S
Gulf J Oncolog; 2019 May; 1(30):22-28. PubMed ID: 31242978
[TBL] [Abstract][Full Text] [Related]
34. Outcomes with nondose-dense chemotherapy for Ewing sarcoma: A practical approach for the developing world.
Parambil BC; Vora T; Sankaran H; Prasad M; Bakshi A; Puri A; Gulia A; Qureshi S; Laskar S; Khanna N; Shah S; Ramadwar M; Kembhavi S; Chinnaswamy G; Banavali S
Pediatr Blood Cancer; 2020 Nov; 67(11):e28604. PubMed ID: 32706522
[TBL] [Abstract][Full Text] [Related]
35. Pelvic Ewing sarcoma: a retrospective analysis of 241 cases.
Hoffmann C; Ahrens S; Dunst J; Hillmann A; Winkelmann W; Craft A; Göbel U; Rübe C; Voute PA; Harms D; Jürgens H
Cancer; 1999 Feb; 85(4):869-77. PubMed ID: 10091764
[TBL] [Abstract][Full Text] [Related]
36. Ewing sarcoma of the hand or foot.
Froeb D; Ranft A; Boelling T; Paulussen M; Klco-Brosius S; Jürgens H; Dirksen U
Klin Padiatr; 2012 Oct; 224(6):348-52. PubMed ID: 23143762
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age.
Paioli A; Luksch R; Fagioli F; Tamburini A; Cesari M; Palmerini E; Abate ME; Marchesi E; Balladelli A; Pratelli L; Ferrari S
J Chemother; 2014 Feb; 26(1):49-56. PubMed ID: 24091100
[TBL] [Abstract][Full Text] [Related]
38. Cyclophosphamide and topotecan as first-line salvage therapy in patients with relapsed ewing sarcoma at a single institution.
Farhat R; Raad R; Khoury NJ; Feghaly J; Eid T; Muwakkit S; Abboud M; El-Solh H; Saab R
J Pediatr Hematol Oncol; 2013 Jul; 35(5):356-60. PubMed ID: 23042020
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcome and relapse patterns in Ewing sarcoma patients with extensive lung/pleural metastases after a complete response to systemic therapy.
Xu J; Zhi X; Xie L; Sun X; Liu X; Liu K; Guo W
BMC Cancer; 2022 May; 22(1):500. PubMed ID: 35524212
[TBL] [Abstract][Full Text] [Related]
40. Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group.
Foulon S; Brennan B; Gaspar N; Dirksen U; Jeys L; Cassoni A; Claude L; Seddon B; Marec-Berard P; Whelan J; Paulussen M; Streitbuerger A; Oberlin O; Juergens H; Grimer R; Le Deley MC
Eur J Cancer; 2016 Jul; 61():128-36. PubMed ID: 27176931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]